Therefore, the aim of the presented study was the analysis of the allele frequencies of the Mdm2 SNP309 in patients with PCa compared to a healthy control group to assess a possible influence of this promoter alteration on cancer risk, histopathological tumour characteristics and prognosis. The gene discussed is MDM2; the disease is cancer.